| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |